Patently Dumb: America’s current patent system inhibits innovation. Here’s how to fix it

Media Article 22 Sep 2017

I-MAK co-director and co-founder Tahir Amin defends the Patent Trial and Appeal Board as a necessary check against unmerited patenting that hurts our ability to solve nationwide challenges like runaway drug prices and slippery patent trolls.

Partner with us now to build
a more just and equitable
medicine system for all.